Stockscreener 앱 받기
19.15
1.32%
0.25
시장 영업 전:
19.29
0.14
+0.73%
전일 마감가:
$18.90
열려 있는:
$19
하루 거래량:
10.79M
Relative Volume:
1.43
시가총액:
$9.84B
수익:
$10.89B
순이익/손실:
$-241.00M
주가수익비율:
-72.10
EPS:
-0.2656
순현금흐름:
$340.00M
1주 성능:
+3.29%
1개월 성능:
+2.41%
6개월 성능:
-38.93%
1년 성능:
-37.91%
1일 변동 폭
$18.92
$19.34
1주일 범위
$17.92
$19.34
52주 변동 폭
$17.40
$37.74
박스터 인터내셔널 Stock (BAX) Company Profile
명칭
Baxter International Inc
전화
(224) 948-2000
주소
ONE BAXTER PARKWAY, DEERFIELD, IL
BAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
19.15 | 9.72B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 194.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.89 | 57.21B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.80 | 38.69B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.27 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.56 | 19.61B | 2.96B | 487.70M | 344.00M | 6.6758 |
박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-31 | 다운그레이드 | Argus | Buy → Hold |
| 2025-08-04 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-08-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-02-26 | 재개 | Goldman | Buy |
| 2025-02-24 | 업그레이드 | Argus | Hold → Buy |
| 2025-02-20 | 재개 | Barclays | Overweight |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-15 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-06-24 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-18 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-18 | 재확인 | Raymond James | Outperform |
| 2022-02-18 | 재확인 | Stifel | Buy |
| 2022-02-18 | 재확인 | UBS | Neutral |
| 2022-02-18 | 재확인 | Wells Fargo | Overweight |
| 2022-02-11 | 개시 | Goldman | Neutral |
| 2022-01-07 | 재개 | Citigroup | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-09-03 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-09-04 | 다운그레이드 | Argus | Buy → Hold |
| 2020-06-24 | 개시 | Oppenheimer | Outperform |
| 2020-03-19 | 업그레이드 | Stifel | Hold → Buy |
| 2020-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-01-02 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | 업그레이드 | Argus | Hold → Buy |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-05-17 | 재개 | Piper Jaffray | Overweight |
| 2018-02-06 | 재확인 | Citigroup | Neutral |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
박스터 인터내셔널 주식(BAX)의 최신 뉴스
Cullen Capital Management LLC Grows Position in Baxter International Inc. $BAX - Defense World
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm - PR Newswire
BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Class Action Alert: Levi & Korsinsky Reminds Baxter International, Inc. (BAX) Investors of December 15, 2025 Deadline - Stockhouse
BAX DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Baxter Investors Have Opportunity to Lead Class Action Lawsuit - marketscreener.com
BAXTER CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Baxter Investors Have Opportunity to Lead Class Action Lawsuit - TMX Newsfile
Investors in Baxter International, Inc. Should Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your RightsBAX - Your Wyoming Link
Deadline Soon: Baxter International, Inc. (BAX) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
BAX DEADLINE: Faruqi & Faruqi Reminds Baxter Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 12, 2025BAX - Morningstar
Syringe Pumps Industry Intelligence Report 2025-2032: Focus on Product Types, Material Types, Mode of Operation, End Users, Regions, Groups, Countries - GlobeNewswire Inc.
Wells Fargo Adjusts PT on Baxter International to $19 From $21, Maintains Equalweight Rating - marketscreener.com
Wells Fargo Maintains Baxter International Inc(BAX.US) With Hold Rating, Cuts Target Price to $19 - 富途牛牛
Parkwood LLC Makes New $9.46 Million Investment in Baxter International Inc. $BAX - MarketBeat
Baxter International Stock: Is BAX Underperforming the Health Care Sector? - Barchart.com
Is Baxter International Offering Long Term Value After Years of Share Price Declines? - Yahoo Finance
BAX Deadline: BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit - PR Newswire
Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrati - pharmiweb.com
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
Baxter International, Inc. (BAX) Shareholders Get Answers in Latest SueWallSt Podcast - ACCESS Newswire
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Baxter reports safety improvements with smart infusion pump integration By Investing.com - Investing.com Canada
Baxter-UTMB Study Shows EMR-Integrated Smart Pumps Boost Safety And Cut Workload - Nasdaq
Citi Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $21 - 富途牛牛
Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity - Business Wire
Q3 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & SuppliesDiversified Stocks - Yahoo Finance
BAXTER CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. - GlobeNewswire
Burned by Baxter International, Inc.? Contact Levi & Korsinsky to SueWallSt And Fight Back - ACCESS Newswire
Baxter International, Inc. (BAX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Baxter (BAX) Valuation Check After Novum IQ Class I Recall and Escalating Securities Lawsuits - simplywall.st
Here’s What Pressured Baxter International (BAX) in Q3 - Insider Monkey
Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - marketscreener.com
Shareholders that lost money on Baxter International, - GlobeNewswire
Investors who lost money on Baxter International, Inc.(BAX) should contact Levi & Korsinsky about pending Class ActionBAX - Morningstar
Portnoy Law Firm Announces Class Action on Behalf of Baxter International, Inc. Investors - GlobeNewswire
Wound Care Market is expected to reach US$ 25.4 billion by 2031 | - openPR.com
Wall Street analysts have consensus hold recommendation for Baxter International Inc. (BAX) - MSN
Wall Street Analysts Have Consensus Hold Recommendation For Baxter International Inc. (BAX) - Finviz
How Investors Are Reacting To Baxter (BAX) Legal Headwinds And Balance Sheet Moves - simplywall.st
BAX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
BAX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - marketscreener.com
Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire
Lowey Dannenberg Notifies Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $250,000 in Losses to Contact the Firm - GlobeNewswire
BAXTER INTERNATIONAL INC. (NYSE: BAX) SHAREHOLDER ALERT - GlobeNewswire
Shareholders that lost money on Baxter International, Inc.(BAX) should contact The Gross Law Firm about pending Class ActionBAX - WV News
SueWallSt Podcast Explains Class Action Against Baxter International, Inc. (BAX) - ACCESS Newswire
Gabelli Funds LLC Boosts Stock Position in Baxter International Inc. $BAX - MarketBeat
KMX DEADLINE: Faruqi & Faruqi Reminds Baxter International Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 2, 2026KMX - TMX Newsfile
BAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Baxter International, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Baxter (BAX): Taking a Fresh Look at Valuation After a Tough Stretch for Shareholders - Yahoo Finance
2025-12-06 | Securities Class Action Lawsuit Filed Against Baxter International, Inc. (BAX)Levi & Korsinsky Represents Shareholders | NYSE:BAX | Press Release - Stockhouse
박스터 인터내셔널 (BAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.95%
0.04%
자본화:
|
볼륨(24시간):